Search details
1.
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
N Engl J Med
; 384(16): 1529-1541, 2021 04 22.
Article
in English
| MEDLINE | ID: mdl-33882206
2.
Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer.
NPJ Breast Cancer
; 8(1): 98, 2022 Aug 29.
Article
in English
| MEDLINE | ID: mdl-36038616
3.
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors.
J Clin Oncol
; 39(22): 2474-2485, 2021 08 01.
Article
in English
| MEDLINE | ID: mdl-33929895
4.
Author Correction: Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer.
NPJ Breast Cancer
; 10(1): 41, 2024 Jun 06.
Article
in English
| MEDLINE | ID: mdl-38844800
5.
High Body Mass Index and Use of Fentanyl Iontophoretic Transdermal System in Postoperative Pain Management: Results of a Pooled Analysis of Six Phase 3/3B Trials.
Pain Ther
; 6(1): 29-43, 2017 Jun.
Article
in English
| MEDLINE | ID: mdl-28004310
6.
The Efficacy and Safety of the Fentanyl Iontophoretic Transdermal System (IONSYS®) in the Geriatric Population: Results of a Meta-Analysis of Phase III and IIIb Trials.
Drugs Aging
; 33(12): 901-912, 2016 12.
Article
in English
| MEDLINE | ID: mdl-27785733
7.
Fentanyl Iontophoretic Transdermal System (IONSYS(®)) can be Safely used in the Hospital Environment with X-Rays, Computerized Tomography and Radiofrequency Identification Devices.
Adv Ther
; 33(9): 1649-59, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27423647
8.
Use of Fentanyl Iontophoretic Transdermal System (ITS) (IONSYS®) in the Management of Patients with Acute Postoperative Pain: A Case Series.
Pain Ther
; 5(2): 237-248, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27817153
9.
The use of epoetin alfa in chemotherapy patients: a consistent profile of efficacy and safety.
Semin Oncol
; 29(3 Suppl 8): 81-7, 2002 Jun.
Article
in English
| MEDLINE | ID: mdl-12082659
10.
LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951).
Eur J Cancer
; 45(10): 1807-14, 2009 Jul.
Article
in English
| MEDLINE | ID: mdl-19419855
11.
5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen.
J Clin Oncol
; 27(31): 5208-12, 2009 Nov 01.
Article
in English
| MEDLINE | ID: mdl-19738118
12.
Managing cancer-related anaemia with epoetin alfa.
Nephrol Dial Transplant
; 17 Suppl 1: 73-7, 2002.
Article
in English
| MEDLINE | ID: mdl-11812917
13.
Neuroprotective properties of epoetin alfa.
Nephrol Dial Transplant
; 17 Suppl 1: 8-12, 2002.
Article
in English
| MEDLINE | ID: mdl-11812906
Results
1 -
13
de 13
1
Next >
>>